Big pharma, Insight journal - Dealtalk, Pharma

Sanofi seeking pharma partners in India for cancer & diabetes drug discovery

Posted on 10 September 2012

Tags: , , ,

The world’s fourth largest drug-maker, Sanofi, will tap Indian talent for its drug discovery in the field of oncology and diabetes and is looking for pharma partners to execute the same.

Sanofi’s head for India R&D, Raman Govindrajan, told Business Line that the new research and development set-up in Bangalore will use the partnership model in drug discovery.

“We have already floated an RFP seeking pharma partners for these activities. This is the first such initiative by Sanofi in India. It has another R&D centre in Goa, which carries out work in the area of drug formulations.

FOCUS AREAS

Mr Govindarajan, who is also the member of Asia-Pacific R&D management for Sanofi, said oral cancers and head and neck cancers are common in South Asia and, hence, there is a need to work on these areas here.

These are also less researched areas, he pointed out. “The kind of R&D undertaken here is more to do with what the disease is all about. It is more to do with clinical research,” he said. During the previous year, Sanofi spent about $4.5 billion on R&D activities globally.

“We are looking at whom we can partner with. We don’t have our own labs. The partners we are looking at can be academics, biotech companies, consultants or pharma companies. We have to identify that there is an unmet medical need and what we can do in that space. We will look at partners who can address those problems,” he explained.

SEVERAL PHARMA PARTNERS

Mr Govindarajan said the proposal will be developed in association with potential pharma partners.

“Sometimes, we realise that one partner is not enough and we scout for more. After that, we go to the board for funding. Then the project goes through an evaluation process and if we are successful in terms of scientific content, relevance, medical needs and doability, only then is the money given,” he said.

He said Sanofi is a pioneer in this model and has had a long history of partnerships.

He said the pharma partners should either have the expertise, knowledge base or skills or a facility.

Hence, there could be several pharma partners who can work together in the area of drug discovery.

 

Related

Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary

Read: Big pharma deal news- latest deal news for top 50 pharma / big pharma companies

Report: Practical Guide to Finding Partners

Report: Partnering Deals and Alliances with Big Pharma

Report: Partnering Deals and Alliances with Sanofi

Related reports: Bigpharma Partnering Yearbook 2013

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Print Friendly, PDF & Email

Leave a Reply